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Several neurological complications have been described after inﬂuenza vaccination. Oculomotor palsy has not been yet related
with inﬂuenza vaccine. We report a 79-year-old man who developed an acute transient right oculomotor palsy two days after a
routine inﬂuenza vaccination, for which no other cause was identiﬁed. There was no evidence of diabetes, glucose intolerance,
high blood pressure, hipercholesterolemia, smoking,obesity, systemic vasculitis, or other risk factor for ischemic neuropathy. The
cerebrospinal ﬂuidwasnormalaswell asthe MRI andMRAscans.The diﬀerential diagnosisandthe possible relationshipbetween
the vaccine and the oculomotor palsy are discussed.
1.Introduction
The inﬂuenza vaccine is consideredsafe and is widely recom-
mended to prevent inﬂuenza virus infection complications
in high risk populations [1]. Side eﬀects include soreness at
the vaccination site, fever, malaise, and myalgias, especially
in patients who had never exposed to the inﬂuenza virus
antigens present in the vaccine [2, 3].
Neurological complications have been described after
inﬂuenza vaccination, including Guillain-Barre syndrome
[4–8], chronic inﬂammatory demyelinating polyneuropathy
(CIDP) [9], acute disseminated encephalomyelitis [10–12]
acute transverse myelitis [12–15], optic neuritis [16, 17],
cerebellarataxia [18], giantcell arteritis [19], dermatomyosi-
tis [20], hypoglossal palsy [21], peripheral facial palsy [22–
24] and vasculitic ulnar mononeuropathy [25] .A sf a ra sw e
know oculomotor mononeuropathy has not been described
as a complication of inﬂuenza vaccine. We report a patient
with sudden development of painful right oculomotor palsy
following inﬂuenza vaccination with complete recovery after
two weeks.
2.Case Report
A 79-year-old white male presented with a history of
sudden development of right painful ophthalmoplegia,
diplopia, and palpebral ptosis accompanied by nausea,
vomiting, and headache. The symptoms developed two
days after the inﬂuenza vaccination (Vaxi-grip, Aventis
Pasteur, Lyon, France). The vaccine contained inactivated
A/New Caledonia/20/99(H1N1)-like virus, A/Wisconsin/67/
2005(H3N2)-like virus, B/Malaysia/2506/2004-like virus,
which had been recommended for the 2007 season on the
South hemisphere. There was no history of diabetes, glucose
intolerance,arterialhypertension,hypercholesterolemia,sys-
temic vasculitis, smoking, obesity, or other risk factors for
ischemic oculomotor nerve palsy. There was no personal or
family history of neurological disorders.
General physical examination was normal. The blood
pressure was 130/80mmHg. The neurological examination
showed right oculomotor palsy with pupil preservation. All
other cranial nerves were preserved. The muscle strength,
deep tendon reﬂexes, and muscle tone and coordination
were normal. The plantar response was normal bilaterally.2 ISRN Neurology
Sensory examination did not show abnormalities. The gait
was normal, and Romberg test was negative.
The workup showed normal red and white blood
cell count as well as platelet count, sedimentation rate,
sodium, potassium, calcium, urea, creatinine, total choles-
terol, triglycerides, fast glucose, glucose tolerance test, and
glycosylated hemoglobin levels. The routine cerebrospinal
ﬂuid was normal. The head CT scan did not show any
abnormality as well as brain magnetic resonance imaging
(MRI)andmagnetic resonanceangiography(MRA).Alltests
were done following informed consent of the patient, who
agreed with the publication of the case.
The pain was treated with symptomatic analgesics. After
two weeks of symptoms, a gradual and complete recovery
was observed, without any speciﬁc treatment.
3.Discussion
Neurological complications are rare after inﬂuenza vacci-
nation, usually restricted to a few case reports [25]. The
exceptions were theGuillain-Barre syndrome outbreak in the
USA in 1976 and 1977 after a massive use of the swine-ﬂu
vaccine in over than 40 million people and the peripheral
facial palsy outbreak in Switzerland between 2000 and 2001
after the use of the intranasal presentation of the vaccine,
both no longer used nowadays [7, 24]. Most of the cases
occurred within 4 weeks after the vaccination. The current
inactivated inﬂuenza vaccine is considered safe [26]. In1990,
the Vaccine Adverse Events Reporting System (VAERS) was
criated by the Centers for Disease Control for vigillance of
vaccine side eﬀects. Lasky et al. [6] have found an incidence
of 1-2 Guillain-Barre cases/1.000.000 of vaccinated between
1992 and 1994. Others reports have found a small increased
risk of GBS after inﬂuenza vaccination in the subsequent
years [4, 27].
Sudden oculomotor palsy with or without other neuro-
logicaldeﬁcitscan occurin severaldiﬀerent conditionsalong
the pathway of the nerve from the brainstem to the extrinsic
eye muscles inside the orbit. Midbrain, interpeduncular
cistern, cavernous sinus and orbit are some of the sites
of possible injury of the oculomotor nerve through its
pathway. The oculomotor palsy can be complete when the
pupil is aﬀected and incomplete when it is spared. Usually
incomplete lesions are caused by ischemia of the nerve
in patients with diabetes, arterial hypertension, obesity,
smoking, or a combination of risk factors [28–30]. On the
other hand, complete lesions are most frequently observed
in compressive lesions of the nerve such as aneurysm of the
posterior communicating artery, since the parasympathetic
ﬁbers are localized in the periphery of the nerve.
Since all possible underlying structural causes of oculo-
motor nerve injury were ruled out by clinical, laboratorial,
and imaging workup, the inﬂuenza vaccine may be the
causal factor of the transient oculomotor nerve palsy in
the present case. The inﬂuenza vaccine probably causes
damage to the myelin sheaths and surrounding axons
in complications such as Guillain-Barre syndrome, acute
disseminated encephalomyelitis, transverse myelitis, Bell’s
palsy, and opticneuritis. In theory, it isprobablethat it could
trigger oculomotor palsy by the same mechanism. The fast
recovery of the symptoms in our patient corroborates the
hypotesis of demyelination, althought there is no pathologi-
cal comprovation for this theory.
Although it has not been possible to establish a deﬁnite
causal relationship between the inﬂuenza vaccine and the
oculomotor palsy in the present case, no better explanation
was found. It is widely known that ischemia is usually the
cause of incomplete oculomotor palsy; however, the absence
of recognized risk factors for atherosclerosis in our patient,
exceptforadvancedage,makesthispossibilityunlikely.Thus,
we would like raising the possibility of such complication.
Since vaccines may cause central and peripheral nervous
system disorders, we think being reasonable to consider
this possibility at the diﬀerential diagnosis. This is the
ﬁrst oculomotor palsy possibly associated with inﬂuenza
vaccination described in the literature to date. A case of
isolated oculomotor palsy has been previously reported after
measles vaccination in a child [31]. Further population
based studiesare necessary to prove the relationship between
inﬂuenza vaccine and oculomotorpalsy, aswell astoﬁnd out
its underlying mechanisms.
Although inﬂuenza vaccine is routinely recommended in
high-risk groups, rare neurological complications, including
oculomotor palsy can be seen. However, it is important
to highlight that such complications do not outweigh the
beneﬁcial eﬀects of the inﬂuenza vaccine in high risk
populations [32].
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